PharmiWeb.com - Global Pharma News & Resources

Research and development - Press Releases

Date Title Company
12-Dec-2022 Heart surgery and impact on mental health among new national priorities for congenital heart disease research University of Birmingham
12-Dec-2022 NICE process “not appropriate for a rapidly evolving virus” Kidney Research UK
12-Dec-2022 Novozymes and Chr. Hansen to combine and create a leading global biosolutions partner Novozymes and Chr. Hansen
07-Dec-2022 SK pharmteco announces new standalone Analytical Services from its SK biotek Ireland Swords Campus SK pharmteco
07-Dec-2022 The Lancet Publishes Results from Two Bimekizumab Phase 3 Studies in Psoriatic Arthritis UCB
06-Dec-2022 MHRA approves Adtralza®▼(tralokinumab) for the treatment of adolescent patients with moderate-to-severe atopic dermatitis, who are candidates for systemic therapy LEO Pharma
06-Dec-2022 Evonik launches plant-based squalene to boost vaccine efficacy Evonik
06-Dec-2022 Pumas-AI Hires Dr. Salim Bouchene and Expands Consulting Practice in Europe Pumas-AI
06-Dec-2022 Regulations slowing down digital transformation for most drug development companies AspenTech
06-Dec-2022 Documentary explores tuberculosis amongst Canterbury’s homeless University of Kent
06-Dec-2022 ONK Therapeutics Boosts Drug Development Experience and Expands US Presence with the Appointment of Bruce McCreedy Ph.D. as Chief Scientific Officer ONK Therapeutics
06-Dec-2022 TOPTICA Projects: Management Board Expanded TOPTICA Projects
06-Dec-2022 Biognosys Launches New Version of Spectronaut® at HUPO International Proteomics Congress Biognosys
06-Dec-2022 HUMAN celebrates its 50th anniversary HUMAN
06-Dec-2022 Alfa Chemistry Diversifies Its Chemical Supply by Adding Luminescent Materials, Biomedical Polymers, and Electroplating Intermediates Alfa Chemistry
01-Dec-2022 RetinAI launches Discovery CORE™: an AI-powered, collaborative platform to accelerate Clinical and Academic Research, and RWE analysis in ophthalmology RetinAI
29-Nov-2022 Rewind Therapeutics Appoints Dr. Stephen Burbidge to its Management Team Rewind Therapeutics
29-Nov-2022 MicrobioSeq Boosts Scientific Research with Gene Expression Analysis CD Genomics
25-Nov-2022 CD Formulation Stresses the Importance of Increased Bioavailability Excipients in Drug Formulation CD Formulation
25-Nov-2022 CD Formulation Launches GalNAc Coupling Modification Services for the Development of Drug Delivery Systems CD Formulation